MBTPS1 and cancer: Although there is a strong, indisputable, causal association between adverse SphK/S1P signaling and cancer, to date there have been no reports of SphK/S1PR mutations linked to cancer development and it has been suggested that cancer cells develop a dependence on SphK cellular signaling, referred to as “non-oncogene addiction” [86].